+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

MK-4280A (favezelimab and pembrolizumab) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

MK-4280A (favezelimab and pembrolizumab) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035 - Product Thumbnail Image

LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035

  • Report
  • April 2020
  • 80 Pages
  • Global
From
Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Health Economics and Outcomes Research (HEOR) Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Health Economics and Outcomes Research (HEOR) Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • June 2022
  • 115 Pages
  • Global
From
Proteasome Inhibitors Market Report and Forecast 2024-2032 - Product Thumbnail Image

Proteasome Inhibitors Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 198 Pages
  • Global
From
Antibody Drug Conjugates Market Report and Forecast 2024-2032 - Product Thumbnail Image

Antibody Drug Conjugates Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 140 Pages
  • Global
From
Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 184 Pages
  • Global
From
Asia Pacific Antibody Drug Conjugates Market, By Region, Competition Forecast and Opportunities, 2018-2028F - Product Thumbnail Image

Asia Pacific Antibody Drug Conjugates Market, By Region, Competition Forecast and Opportunities, 2018-2028F

  • Report
  • November 2023
  • 130 Pages
  • Asia Pacific
From
Turkey Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

Turkey Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 80 Pages
  • Turkey
From
Peptide Drug Conjugates Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Peptide Drug Conjugates Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 186 Pages
  • Global
From
Japan Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Japan Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 80 Pages
  • Japan
From
Antibody-drug Conjugates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Antibody-drug Conjugates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
Histone Deacetylase 6 - Pipeline Insight, 2024 - Product Thumbnail Image

Histone Deacetylase 6 - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Aurora Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Aurora Kinase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more